Back to Search
Start Over
Osimertinib in Resected EGFR-Mutated Non-Small-Cell Lung Cancer
- Source :
- NEW ENGLAND JOURNAL OF MEDICINE, r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau, instname, r-IIB SANT PAU: Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau, Institut dInvestigació Biomèdica Sant Pau (IIB Sant Pau)
- Publication Year :
- 2020
- Publisher :
- MASSACHUSETTS MEDICAL SOC, 2020.
-
Abstract
- BackgroundOsimertinib is standard-of-care therapy for previously untreated epidermal growth factor receptor (EGFR) mutation-positive advanced non-small-cell lung cancer (NSCLC). The efficacy and safety of osimertinib as adjuvant therapy are unknown. MethodsIn this double-blind, phase 3 trial, we randomly assigned patients with completely resected EGFR mutation-positive NSCLC in a 1:1 ratio to receive either osimertinib (80 mg once daily) or placebo for 3 years. The primary end point was disease-free survival among patients with stage II to IIIA disease (according to investigator assessment). The secondary end points included disease-free survival in the overall population of patients with stage IB to IIIA disease, overall survival, and safety. ResultsA total of 682 patients underwent randomization (339 to the osimertinib group and 343 to the placebo group). At 24 months, 90% of the patients with stage II to IIIA disease in the osimertinib group (95% confidence interval [CI], 84 to 93) and 44% of those in the placebo group (95% CI, 37 to 51) were alive and disease-free (overall hazard ratio for disease recurrence or death, 0.17; 99.06% CI, 0.11 to 0.26; P
Details
- ISSN :
- 00284793
- Database :
- OpenAIRE
- Journal :
- NEW ENGLAND JOURNAL OF MEDICINE, r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau, instname, r-IIB SANT PAU: Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau, Institut dInvestigació Biomèdica Sant Pau (IIB Sant Pau)
- Accession number :
- edsair.dedup.wf.001..33ef27ca238c74444dfa6bf777d3afd2